Ukuhlolwa kweVAP Cholesterol Kungayibona Ingozi Yakho Yezifo Zenhliziyo?
Ukuhlola kwe-VAP cholesterol, noma ukuhlolwa kwephrofayela yokuzenzakalela ngokuqondile, kuningiliziwe ukuthi uhlolo lwe-cholesterol oluvamile noma iphaneli ye-lipid. Ihlanganisa izilinganiso ezihambisana nezinjongo ezintsha zokwelashwa kwe-cholesterol futhi zingase zikhethwe ngabahlinzeki abaqapha ukwelashwa kwe-cholesterol ephezulu. Kungase kubone abantu abaningi abasengozini yesifo senhliziyo kamuva ekuphileni.
Ukuhlolwa kwephrofayili yokuzenzakalela (VAP) eyenziwe ngabacwaningi eBirmington, Alabama futhi kwaqaliswa ukuhweba ngu-Atherotech, Inc. Ukumaketha kwamkelwa yi-FDA ngo-2007.
Ukuhlolwa kwe-VAP kuqhathaniswa nephrofayela ye-Lipid ye-Cholesterol
Isivivinyo se-cholesterol yendabuko isebenza ngokuphefumula igazi esiteshini esiphakeme se-centrifuge ukuhlukanisa i-lipids (amafutha). Lokhu kuhlolwa okujwayelekile, okubizwa ngokuthi iphrofayili ye-lipid, kwahlukanisa izigaba ezintathu zezilonda : i-lipoproteins ephakeme kakhulu, noma i-HDL; i-lipoproteins ephansi kakhulu, noma i-LDL; futhi i-triglycerides, uhlobo oluyinhloko lamafutha emzimbeni.
Kodwa cishe isigamu sabo bonke abantu abaye bahlaselwa isifo senhliziyo, iphrofayli ejwayelekile ye- lipid ayibonakali okungavamile. Ngokusho kuka-Atherotech, ukuhlolwa kwe-VAP kuzokwazi ukubona abantu ababili abasengozini yesifo senhliziyo, uma kuqhathaniswa namasu wendabuko.
Izinyathelo zokuhlolwa kwe-cholesterol zendabuko:
- Izinga le-LDL
- Izinga le-HDL eliphelele
- Izinga le-Triglyceride
Esivivinyweni se-cholesterol yendabuko, la mazinga abalwa ngokusebenzisa ifomula ethize. Ngokuphambene, ukuhlola okusha kwe-VAP kungalinganisa la mazinga ngokuqondile.
Indlela iVAP Test Works ngayo
Njengesiprofayili se-lipid, ukuhlolwa kwe-VAP kusebenza ngokuphenya isampula segazi ukuhlukanisa i-lipids ngesisindo. Kodwa ukuhlolwa kwe-VAP kunikeza imininingwane eminingi kune-test yesintu.
Isibonelo, ukuhlola kwe-VAP kuhlukanisa i-cholesterol ye-LDL ngobukhulu obukhulu futhi iphula i-cholesterol ye-HDL ibe yizigaba ezincane. Ucwaningo lwamanje lubonisa ukuthi amaphethini athile we-LDL ubukhulu bezinhlayiyana zingabonisa ingozi enkulu yokuthuthukiswa kwesifo senhliziyo. Ukwengeza, i-subclass eyodwa ye-HDL, i-HDL2, ibhekwa njengenhliziyo evikelekile kakhulu.
I-VAP test iphinde ilandise ezinye igazi lipids ukuthi iphrofayli yamanje zamanje ayinaki, njenge-low-density lipoprotein (VLDL); I-intermediate-density lipoprotein (i-IDL); futhi i-lipoprotein (a) [Lp (a)]. Abacwaningi be-Atherotech bathi ukulinganisa lezi zigaba zamapayipi engeziwe kanye nama-subclasses kungabonisa ulwazi oluthe xaxa mayelana nesengozini yokuthuthukisa isifo senhliziyo, okungavivinywa ukuhlolwa kwesintu.
Okushiwo yi-VAP Test Measures
- Ingqikithi ye-VLDL: Amazinga e-VLDL aphakanyisiwe afana nengozi ekhulayo yesifo senhliziyo nesifo sikashukela.
- I-Sum Total Cholesterol: Isibalo samazinga e-HDL, i-LDL nama-VLDL.
- Ingqikithi engekho i-HDL: Isamba samazinga kuphela e-LDL ne-VLDL; inani eliphakeme likhombisa ingozi enkulu yokuthuthukisa isifo senhliziyo.
- Ingqikithi ye-B100: I-Apolipoprotein B100 iyasiza ukudala, ukuthwala nokuletha "i-cholesterol embi" kumaseli; ukulinganisa ama-level angu-B100 amazinga ekunqumeni uhlobo kanye / noma imbangela ye-cholesterol ephezulu.
- I-Lp (a) i-cholesterol: Ucwaningo lubonisa ukuthi uLp (a), efana neLDL, ifa eliyilungu legazi elibangelwa yi-atherosclerosis.
- I-IDL: I-lipoprotein yesilinganiso esiphakathi; ngokusho kuka-Atherotech, le nombolo iphakanyisiwe phakathi kwabantu abanomlando womndeni wesifo sikashukela.
- I-LDL-RC: i- LDL eboshwe ku-pro-protein esebenzayo; lolu hlobo lwe-LDL litholakala esakhiweni sama-atherosclerotic plaques emzimbeni, okuyisinye sezici eziyinhloko zesifo se-artery futhi-uma behlukana - umqali oyinhloko wokuhlasela kwenhliziyo.
- I-Sum Yonke LDL-C: Isibalo se-Lp (a), i-IDL ne-LDL.
- Iphethini lomthamo we-LDL: Ibikwe njengenye yezinhlobo ezintathu - A, A / B noma B. Kuphethini A, ama-molecule e-LDL ayamakhulu futhi aphansi kakhulu, okwenza kube lula umzimba ukuba ususe. Kuphethini A / B, kukhona inhlanganisela yama-molecule alula futhi aqinile. Kuphethini B, amancane ama-molecule amaningi aphezulu. Ngokusho kuka-Atherotech, iziguli ezinezinhlayiyana ezincane ezinama-LDL (iphethini B) zinengozi enkulu yokukhula kwesifo senhliziyo kuneziguli ezine-LDL pattern pattern A.
- I-HDL-2: I-subclass ye "cholesterol enhle" evikela kakhulu isifo senhliziyo. Inombolo ephansi lapha ingase isho ingozi eyengeziwe yokwelashwa komzimba wegazi, ngisho nalabo abanezinga elivamile le-cholesterol.
- I-HDL-3: Enye i-classic ye-HDL, engavimelani ne-artery coronary isifo esifanayo ne-HDL-2.
- I-VLDL-3: I-lipoprotein ecebile kakhulu e-triglyceride; Ucwaningo oluthile lubonisa ukuhlanganiswa okungenzeka phakathi kwezinombolo eziphezulu ze-VLDL-3 nokuthuthukiswa kwesifo sikashukela.
Futhi, ukuhlolwa kwe-VAP kunikeza abantu abanomqondo ongcono wokungcupheni kwabo kwisifo se- metabolic syndrome , inhlanganisela yezici eziphakamisa kakhulu ingozi umuntu oyokhipha isifo sikashukela noma isifo senhliziyo.
Imikhombandlela yemigomo ye-Cholesterol yokwelashwa evela ku-ADA / ACC 2008 IsiTatimende soVumelwane sibandakanya izinhloso ze-LDL-C, okungezona i-HDL-C ne-APOB, ezifakwe ku-VAP kodwa aziyona ingxenye yokuhlolwa kwe-cholesterol eyisisekelo.
Imithombo:
Bioletto, Silvana, Alain Golay, uRobert Munger, uBarbara Kalix noRichard W. James. "I-Hyperinsulinemia enamandla ne-Low-Low-Density kanye ne-Low-Density Lipoprotein Izifingqo ezincwadini ze-Obese." I-American Journal of Nutrition Clinic 71 (2000): 443-449.
Isigebengu, uKristin. "I-Lipoprotein i-Phenotype ne-Genotype ehlukile." CDC.gov. 2 uNhlolanja 2007. Izikhungo zokuLawula izifo.
"I-Fact Sheet: I-VAP Cholesterol Test." Ukuhlolwa Kwe-Cholesterol Eyinkimbinkimbi Kakhulu - i-VAP . I-Atherotech, Inc.
Kulkarni, KR, DW Garber, SM Marcovina kanye noJP Segrest. "I-Quantification ye-Cholesterol kuyo yonke i-Lipoprotein Classes nge-VAP-II Method." I-Journal ye-Lipid Research. 35 (1994) 159-168.
> Abasebenzi beMayo Clinic. "Ukuhlolwa kwe-Cholesterol: Ukuhlunga i-Lipids." MayoClinic.com . 1 Febhuwari 2007. I-Mayo Clinic.
"I-Metabolic Syndrome." I-Metabolic Syndrome . 2014. American Heart Association.
I-Singh, SK, i-MV Suresh, i-B Voleti ne-Agrawal. "I-Connection Between C-proactive esebenzayo ne-Atherosclerosis." Ama-Annal of Medicine. 40.2. 16 I-NOV 2007 110-120.
Ziajka, Paul. "Ukusebenzisa i-VAP Yandisa Ukuhlolwa Kwe-lipid kusuka ku-Atherotech ukuze kuthuthukiswe izinhlelo eziphuthumayo zokwelapha iziguli." 2008. i-Atherotech.